Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP337293.RAK6u7K9zrjRFBiClXde_WeBhKJXouJQeW35yIRegU6AE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP337293.RAK6u7K9zrjRFBiClXde_WeBhKJXouJQeW35yIRegU6AE130_assertion type Assertion NP337293.RAK6u7K9zrjRFBiClXde_WeBhKJXouJQeW35yIRegU6AE130_head.
- NP337293.RAK6u7K9zrjRFBiClXde_WeBhKJXouJQeW35yIRegU6AE130_assertion description "[Finally, our results have clinical implications, as inhibiting ras and/or its downstream effectors, such as AKT and STAT3/5, could provide alternative means to treat low-grade, superficial papillary bladder tumors, the most common tumor in the urinary system.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP337293.RAK6u7K9zrjRFBiClXde_WeBhKJXouJQeW35yIRegU6AE130_provenance.
- NP337293.RAK6u7K9zrjRFBiClXde_WeBhKJXouJQeW35yIRegU6AE130_assertion evidence source_evidence_literature NP337293.RAK6u7K9zrjRFBiClXde_WeBhKJXouJQeW35yIRegU6AE130_provenance.
- NP337293.RAK6u7K9zrjRFBiClXde_WeBhKJXouJQeW35yIRegU6AE130_assertion SIO_000772 17256055 NP337293.RAK6u7K9zrjRFBiClXde_WeBhKJXouJQeW35yIRegU6AE130_provenance.
- NP337293.RAK6u7K9zrjRFBiClXde_WeBhKJXouJQeW35yIRegU6AE130_assertion wasDerivedFrom befree-20140225 NP337293.RAK6u7K9zrjRFBiClXde_WeBhKJXouJQeW35yIRegU6AE130_provenance.
- NP337293.RAK6u7K9zrjRFBiClXde_WeBhKJXouJQeW35yIRegU6AE130_assertion wasGeneratedBy ECO_0000203 NP337293.RAK6u7K9zrjRFBiClXde_WeBhKJXouJQeW35yIRegU6AE130_provenance.